Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | DCVax-L |
| Trade Name | |
| Synonyms | DCVax-Lung |
| Drug Descriptions |
DCVax-L is a lung cancer vaccine composed of patient-derived dendritic cells that have been transduced with a patient tumor-specific antigen, potentially resulting in increased anti-tumor immunity (PMID: 29843811). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C26446 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| DCVax-L | DCVax-L | 0 | 2 |
| DCVax-L + Nivolumab | DCVax-L Nivolumab | 0 | 1 |